MLchartDataset catalogue

DA-EPOCH-R regimen

Term · Oncology and biomedicine · MLC-T-ONC-002271

An abbreviation for a chemotherapy combination used to treat certain types of non-Hodgkin lymphoma. It includes the drugs etoposide phosphate, prednisone, vincristine sulfate (Oncovin), cyclophosphamide, doxorubicin hydrochloride (hydroxydaunorubicin), and rituximab. During each treatment cycle, the doses of some of the drugs may be increased or decreased to allow the patient to receive the dose that works the best with the fewest side effects. Also called DA-EPOCH-R, dose-adjusted EPOCH-R, and dose-adjusted EPOCH-R regimen.

Table 1. Record
IdentifierMLC-T-ONC-002271
FieldOncology and biomedicine
SynonymsDA-EPOCH-R; dose-adjusted EPOCH-R; dose-adjusted EPOCH-R regimen
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-002271",
  "term": "DA-EPOCH-R regimen",
  "field": "Oncology and biomedicine",
  "definition": "An abbreviation for a chemotherapy combination used to treat certain types of non-Hodgkin lymphoma. It includes the drugs etoposide phosphate, prednisone, vincristine sulfate (Oncovin), cyclophosphamide, doxorubicin hydrochloride (hydroxydaunorubicin), and rituximab. During each treatment cycle, the doses of some of the drugs may be increased or decreased to allow the patient to receive the dose that works the best with the fewest side effects. Also called DA-EPOCH-R, dose-adjusted EPOCH-R, and dose-adjusted EPOCH-R regimen.",
  "synonyms": [
    "DA-EPOCH-R",
    "dose-adjusted EPOCH-R",
    "dose-adjusted EPOCH-R regimen"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/da-epoch-r-regimen/"
}

Record 5,660 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.